EQUILLIUM, INC. Foreign Currency Transaction Gain (Loss), before Tax
EQUILLIUM, INC. (EQ) reported Foreign Currency Transaction Gain (Loss), before Tax of -$100.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2022-05-12
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2022-03-31 was -$100.00K, a 200.00% decline year-over-year.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-12-31 was -$100.00K.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-09-30 was $200.00K.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-06-30 was -$100.00K, a 133.33% decline year-over-year.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for fiscal 2021 was $200.00K.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for fiscal 2020 was -$300.00K, a 2100.00% decline from fiscal 2019.
- EQUILLIUM, INC. foreign currency transaction gain (loss), before tax for fiscal 2019 was $15.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$100.00K 10-Q · filed 2022-05-12 | -$200.00K derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | -$100.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2021-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $100.00K derived: sum of 2 quarters · filed 2022-03-23 | $0.00 derived: sum of 3 quarters · filed 2022-03-23 | $200.00K 10-K · filed 2022-03-23 | |||
| 2021-09-30 | $200.00K 10-Q · filed 2021-11-10 | $100.00K derived: sum of 2 quarters · filed 2021-11-10 | $300.00K 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2021-06-30 | -$100.00K 10-Q · filed 2021-08-10 | -$100.00K 10-Q · filed 2021-08-10 | -$200.00K derived: sum of 3 quarters · filed 2022-05-12 | -$300.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | -$100.00K derived: sum of 2 quarters · filed 2022-05-12 | -$200.00K derived: sum of 3 quarters · filed 2022-05-12 | $100.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$300.00K derived: sum of 2 quarters · filed 2022-03-23 | $0.00 derived: sum of 3 quarters · filed 2022-03-23 | -$300.00K 10-K · filed 2022-03-23 | $300.00K 10-K · filed 2021-03-24 | ||
| 2020-09-30 | -$100.00K 10-Q · filed 2021-11-10 | $100.00K 10-Q · filed 2020-11-10 | $200.00K derived: sum of 2 quarters · filed 2021-11-10 | -$100.00K 10-Q · filed 2021-11-10 | $100.00K 10-Q · filed 2020-11-10 | $532.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $300.00K 10-Q · filed 2021-08-10 | -$44.00K 10-Q · filed 2021-08-10 | $632.00K derived: sum of 3 quarters · filed 2021-08-10 | $620.00K derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-13 | $332.00K derived: sum of 2 quarters · filed 2021-05-13 | $320.00K derived: sum of 3 quarters · filed 2021-05-13 | $320.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $20.00K derived: sum of 2 quarters · filed 2021-03-24 | $20.00K derived: sum of 3 quarters · filed 2021-03-24 | $15.00K 10-K · filed 2021-03-24 | |||
| 2019-09-30 | -$12.00K 10-Q · filed 2020-11-10 | -$12.00K derived: sum of 2 quarters · filed 2020-11-10 | -$17.00K 10-Q · filed 2020-11-10 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |